Cellular viability assays were performed as previously described [21 (link),22 (link)]. Briefly, cells were seeded into opaque black 96-well plates. To determine the cellular viability of siRNA-treated cells, reverse lipid-based transfections were performed (RNAiMAX, life technologies, Carlsbad, CA, USA). Following defined incubation periods, cellular viability was assessed using the CellTiter-Blue® reagent (Promega) in a plate reader (VICTORTM X4, Perkin Elmer, Waltham, MA, USA). All experiments were conducted as technical and biological triplicates.
Free full text: Click here